Wells Fargo & Company Karuna Therapeutics, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$161.01 - $317.85 $1.54 Million - $3.03 Million	-9,534 Reduced 25.26%	28,214 $8.93 Million
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $276,464 - $366,156	1,679 Added 4.65%	37,748 $6.38 Million
Q2 2023 Aug 15, 2023	SELL	$176.32 - $240.22 $655,910 - $893,618	-3,720 Reduced 9.35%	36,069 $7.82 Million
Q1 2023 May 12, 2023	BUY	$161.33 - $204.36 $3.11 Million - $3.94 Million	19,271 Added 93.92%	39,789 $7.23 Million
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $1 Million - $1.24 Million	5,247 Added 34.36%	20,518 $4.03 Million

Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $1.31 Million - $2.93 Million	10,557 Added 223.95%	15,271 $3.44 Million
Q2 2022 Aug 12, 2022	SELL	$93.97 - $143.33 $886,794 - $1.35 Million	-9,437 Reduced 66.69%	4,714 $596,000
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $727,409 - $973,581	-7,355 Reduced 34.2%	14,151 $1.8 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $1.18 Million - $1.71 Million	10,700 Added 99.02%	21,506 $2.82 Million
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $452,566 - $562,890	4,472 Added 70.6%	10,806 $1.32 Million
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $294,627 - $372,774	-2,742 Reduced 30.21%	6,334 $723,000
Q1 2021 May 13, 2021	SELL	$95.46 - $133.08 $965,768 - $1.35 Million	-10,117 Reduced 52.71%	9,076 $1.09 Million
Q4 2020 Feb 09, 2021	BUY	$75.23 - $109.23 $133,307 - $193,555	1,772 Added 10.17%	19,193 $1.95 Million
Q3 2020 Nov 05, 2020	BUY	$71.31 - $109.74 $182,054 - $280,166	2,553 Added 17.17%	17,421 $1.35 Million
Q2 2020 Aug 13, 2020	BUY	$62.14 - $117.21 $284,041 - $535,766	4,571 Added 44.39%	14,868 $1.66 Million
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $622,041 - $1.19 Million	10,297 New	10,297 $742,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

333K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account